HOME  | CONTACT  | PATIENT LOGIN  | CLINIC LOGIN  | FAQ
  • PATIENTS &
    HEALTHY VOLUNTEERS
  • INVESTIGATORS
  • CROS / SPONSORS
  • CAREERS
  • TRIAL ALERTS

TRIALS SEARCH
      
  • HEALTH NEWS

  • RSS FEEDS

  • ABOUT TRIALS

  • LINK TO US


View Clinical Trial (Medical Research Study)


An Open-Label Study to Assess the Effect of Dexpramipexole (BIIB050) on the Pharmacokinetics of Warfarin in Healthy Volunteers

This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials

Signup
Browse Studies

City:   Overland Park
State:   Kansas
Zip Code:  
Conditions:   Healthy Volunteers
Purpose:   This study will assess the effect of dexpramipexole on the pharmacokinetics (PK) of the CYP2C9 probe substrate warfarin in healthy volunteers.
Study Summary:   This is a single center open label study to assess the effect of Dexpramipexole on the PK of Warfarin in Healthy Volunteers. The goals of this study are as follows: to assess the effect of dexpramipexole on the pharmacodynamics (PD) of warfarin, to assess the safety and tolerability of dexpramipexole when administered alone, and with warfarin, and to assess the PK of dexpramipexole when administered alone; to explore the influence of genetic variation on the PK and international normalized ratio (INR) of warfarin when administered alone, and with dexpramipexole; and to explore the influence of genetic variation on the PK of dexpramipexole when administered alone.
Criteria:   Inclusion Criteria: - Subjects who, in the opinion of the investigator, are healthy as determined by medical history, physical examination, and 12 Lead ECG. - Adult males/females aged 18 to 55 years inclusive. - Male and female subjects of childbearing age must practice effective contraception during the study and up to 90 days after their last dose of study drug. Exclusion Criteria: - History of malignant disease, including solid tumors and hematologic malignancies. - Clinically significant current active infection or serious infection. - History of gastrointestinal bleeding, peptic ulcer disease, hemorrhoids or epistaxis. - Personal or family history of any bleeding disorder, and/or coagulation profile results outside of normal limits. - Known allergy or hypersensitivity to warfarin.
NCT ID:   NCT01597310
Primary Contact:   N/A
Backup Contact:   N/A
Location Contact:   Overland Park, Kansas
United States



There is no listed contact information for this specific location.

Site Status: N/A

Click here to see:
  • Clinical trials for Healthy Volunteers in Overland Park, Kansas

Data Source:   ClinicalTrials.gov
Date Processed:   May 21, 2013
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


  • NEARBY STUDIES

Welcome to ClinicalConnection.com
 
Clinical Connections Home | Investigators | CROs / Sponsors | Clinical Trials Notification | Search Clinical Trials | About Clinical Trials | Links | Terms And Conditions | Sitemap | Suggestions / Feedback
© 1998-2013 | All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.